Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of siponimod on retinal thickness, a marker of neurodegeneration, in participants with SPMS: Findings from the EXPAND OCT substudy.
Vermersch P, Gold R, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Paul F, Wolf S, Li B, Mousseau MC, Maio-Twofoot T, Shi X, Kappos L. Vermersch P, et al. Among authors: fox rj. Mult Scler Relat Disord. 2025 Jan 4;94:106259. doi: 10.1016/j.msard.2025.106259. Online ahead of print. Mult Scler Relat Disord. 2025. PMID: 39847856
DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial.
Corboy JR, Fox RJ, Cutter G, Engebretson E, Miller A, Morgan C, Gustafson T, Goodman AD, Kannan M, Sriram S, Xia Z, Lynch S, Bowen J, Kister I. Corboy JR, et al. Among authors: fox rj. Mult Scler. 2025 Jan 21:13524585241303489. doi: 10.1177/13524585241303489. Online ahead of print. Mult Scler. 2025. PMID: 39834328
Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial.
Fox RJ, Wiendl H, Wolf C, De Stefano N, Sellner J, Gryb V, Rejdak K, Bozhinov PS, Vitt D, Kohlhof H, Slizgi J, Ondrus M, Sciacca V, Muehler AR; EMPhASIS investigators. Fox RJ, et al. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200208. doi: 10.1212/NXI.0000000000200208. Epub 2024 Apr 25. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38662979 Free PMC article. Clinical Trial.
335 results